Medical experts are sounding the alarm over so-called 'skinny jabs' like Wegovy, revealing that patients may regain most of their lost weight after stopping treatment. The findings raise serious questions about the long-term effectiveness of these popular weight-loss injections.
The Wegovy Weight Rollercoaster
Recent studies show that while semaglutide-based treatments can produce dramatic initial weight loss, the benefits may be short-lived. Patients who discontinued the medication typically regained two-thirds of their lost weight within a year.
Why the Weight Comes Back
The research suggests these injections work by suppressing appetite rather than addressing underlying causes of obesity. When treatment stops, hunger hormones return to previous levels, often leading to rapid weight regain.
NHS Concerns Grow
With the NHS increasingly prescribing these expensive treatments, healthcare professionals are questioning whether they represent a sustainable solution to Britain's obesity crisis. Some experts argue the funds might be better spent on preventive measures and lifestyle interventions.
Patient Experiences
Many users report feeling trapped in a cycle of dependency, needing to continue injections indefinitely to maintain results. The psychological impact of weight fluctuation is emerging as a significant concern among long-term users.
The Future of Obesity Treatment
While these medications offer hope for some, researchers emphasize they should be part of a comprehensive treatment plan including dietary changes and exercise. The medical community continues to debate their appropriate use in long-term weight management strategies.
